CRBP

Corbus Pharmaceuticals Holdings Inc.

Price

$10.87

return (12m)

9.80%

p/e

-1.99

p/bv

1.99

DIVIDEND YIELD

0.00%

CRBP price

Corbus Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CRBP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

20.91%

3 months

37.42%

1 year

9.80%

2 years

-80.54%

5 years

-69.55%

10 years

-91.14%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CRBP

Valuation

P/E

-1.99

Sector -4.26

Industry -4.26

P/BV

1.99

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

1.60

Sector 1.25

Industry 1.25

P/Net Current Assets

2.07

Sector -5.47

Industry -5.47

P/Working Capital

2.01

Sector -1.10

Industry -1.10

EPS

-5.36

Sector -1.94

Industry -1.94

BVPS

5.38

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

0.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

0.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

0.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-99.67%

Sector -61.50%

Industry -61.50%

ROA

-80.24%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

5.71

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.81

Sector 0.43

Industry 0.43

Liabilities/Assets

0.19

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

17.42%

Sector -

Industry -

Fundamentals CRBP

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CRBP Corbus Pharmaceuticals Holdings Inc.	$10.87	3.82%	0.00%	-1.99	1.99	-99.67%	0.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CRBP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings Inc.

Average Investor10 user rating

4.0 (0 people)

United States

17 years

Founded: 2009

2014

Time since IPO - 12 years

76

Employees

Corbus Pharmaceuticals Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $203.11 million, with shareholders equity totaling $102.24 million.

The company employs approximately 76 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Corbus Pharmaceuticals Holdings Inc. reported $- in revenue, generating net income of $-101.90 million.

Key financial metrics include a P/E ratio of -1.99, a price-to-book (P/B) ratio of 1.99, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRBP.

Market cap

$203.11 million

Net worth

$102.24 million

$102,240,000.00

Assets

$126.99 million

$126,990,000.00

Total Shares Outstanding

19.00 million

19,000,000

Average Daily Trading Volume

$425.77 Thousand

$425,772.32

Sector

Health Care

Industry

Biotechnology

CRBP

CRBP revenue and profits

Financial Results CRBP

DRAG THE FRAME TO SEE MORE DATA

CRBP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Corbus Pharmaceuticals (CRBP) today?

A cotação de Corbus Pharmaceuticals (CRBP) hoje está em US$ 10.87, com uma variação de 9.8% em relação ao último ano. A cotação de Corbus Pharmaceuticals (CRBP) iniciou o ano negociando na casa dos US$ 8.14 e hoje está em US$ 10.87. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Corbus Pharmaceuticals (CRBP) e dados de ações do Ibovespa e mercados internacionais.

Quando Corbus Pharmaceuticals (CRBP) paga dividendos?

Corbus Pharmaceuticals (CRBP) não distribuiu dividendos no último ano.

Is Corbus Pharmaceuticals (CRBP) a good investment?

Atualmente, Corbus Pharmaceuticals (CRBP) está cotada a US$ 10.87, com um P/L de -1.99, representando um desvio de -162% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 9.8 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 9.80%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Corbus Pharmaceuticals (CRBP) stock?

Investir em ações de Corbus Pharmaceuticals (CRBP) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Corbus Pharmaceuticals (CRBP) yield today?

A rentabilidade de Corbus Pharmaceuticals (CRBP) foi de 20.91% no último mês, 9.80% no último ano e -69.55% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Corbus Pharmaceuticals (CRBP) hoje, o investimento total seria de US$ 1,087.00, com base na cotação atual de US$ 10.87.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,193.53
Em 5 anos: US$ 330.99
Em 10 anos: US$ 96.31

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CRBP

Corbus Pharmaceuticals Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CRBP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CRBP WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings Inc.

United States

17 years

2014

76

PROFIT X PRICE CRBP

Financial Results CRBP

CRBP cash flow

Asset, Revenue and Profit Growth - CRBP

CRBP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions